... early course of schizophrenia, a new potential avenue of treatment for schizophrenia may be to use anti-inflammatory agents. Although some anti-inflammatory medications have already been studied, ...
... of this molecular process is a first step toward improved diagnosis and more effective treatment of schizophrenia and other related disorders. What is schizophrenia?
Schizophrenia is a mental ...
... in schizophrenia," the authors write.
Jayashri Kulkarni, M.B.B.S., M.P.M., ... promising new area for future treatment of schizophrenia and potentially for other severe mental illnesses," they conclude. ...
... of subjects reported that they were simultaneously treated with more than one antipsychotic drug, an unapproved treatment for schizophrenia. The most common unapproved drug combination was the use of ...
... lack of NMDA receptors or that the NMDA receptors on this neuron are not functioning fully. As a result of this research, scientists have a whole new area to explore in the treatment of schizophrenia.
... What processes tip the balance between the ultra-high risk states and the development of schizophrenia? One candidate mechanism is cerebral inflammation, studied by Dr Bart van Berckel and colleagues ...
... occur in schizophrenia. The study breaks new ground in the strategy used to develop new pharmacological treatments for schizophrenia, explained David Lewis, M.D., UPMC Endowed Chair in Translational ...
... corresponding author of the paper from Imperial College London said: "The first step towards better treatments for schizophrenia is to really understand what is going on, to find out what genes are ...
... gene controls this brain enzyme. Better understanding of the relationship could lead to new drug treatments for schizophrenia, the severe brain disorder that affects about 1 percent of the population ...
... hyperactivity disorder (ADHD). It could also allow them to provide more appropriate treatment. Combining schizophrenia's cognitive warning signs with family history and signs of worsening daily ...
... in NMDA glutamate receptor function.
To put it more simply, although D-serine is used as a treatment for schizophrenia, it is metabolized by DAAO, reducing its availability in the brain. So, using ...
... that remains in the brain, perhaps we can help the symptoms."
Currently the only drug treatment for schizophrenia is an antipsychotic. "The drugs address the hallucinations and calm down the patient, ...
WASHINGTON, Aug. 14 (UPI) -- Schering-Plough Corp.'s asenapine has been cleared for sale as a treatment for schizophrenia and bipolar disorder in adults, U.S. authorities said.
... or workplace. More than half of the subjects in both groups had never received treatment for schizophrenia.
"The lack of any particular distinguishing features and the extremely low base rate ...
... Canada Inc.
"It has enabled us to build up a valuable international picture of the demographics and treatment of schizophrenia across ten European countries and 27 countries from East Asia, Latin ...
